期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
An Overview of the Role of Peroxisome Proliferator-activated Receptors in Liver Diseases 被引量:2
1
作者 Zahra Changizi Forough Kajbaf azam moslehi 《Journal of Clinical and Translational Hepatology》 SCIE 2023年第7期1542-1552,共11页
Peroxisome proliferator-activated receptors(PPARs)are a superfamily of nuclear transcription receptors,consisting of PPARa,PPARy,and PPARβ/δ,which are highly expressed in the liver.They control and modulate the expr... Peroxisome proliferator-activated receptors(PPARs)are a superfamily of nuclear transcription receptors,consisting of PPARa,PPARy,and PPARβ/δ,which are highly expressed in the liver.They control and modulate the expression of a large number of genes involved in metabolism and energy homeostasis,oxidative stress,inflammation,and even apo-ptosis in the liver.Therefore,they have critical roles in the pathophysiology of hepatic diseases.This review provides a general insight into the role of PPARS in liver diseases and some of their agonists in the clinic. 展开更多
关键词 LIVER Endoplasmic reticulum stress Nonalcoholic fatty liver dis-ease PPARa PPAR PPARβ/δ
原文传递
Role of SREBPs in Liver Diseases: A Mini-review 被引量:17
2
作者 azam moslehi Zeinab Hamidi-zad 《Journal of Clinical and Translational Hepatology》 SCIE 2018年第3期332-338,共7页
Sterol regulator element binding proteins(SREBPs)are a family of transcription factors involved in the biogenesis of cholesterol,fatty acids and triglycerides.They also regulate physiological functions of many organs,... Sterol regulator element binding proteins(SREBPs)are a family of transcription factors involved in the biogenesis of cholesterol,fatty acids and triglycerides.They also regulate physiological functions of many organs,such as thyroid,brain,heart,pancreas and hormone synthesis.Beside the physiological effects,SREBPs participate in some pathological processes,diabetes,endoplasmic reticulum stress,atherosclerosis and chronic kidney disease associated with SREBP expression changes.In the liver,SREBPs are involved in the pathogenesis of nonalcoholic fatty liver disease,nonalcoholic steatohepatitis,hepatitis and hepatic cancer.There are several SREBP inhibitors that have potential for treating obesity,diabetes and cancer.This review assesses the recent findings about the roles of SREBPs in the physiology of organs'function and pathogenesis of liver diseases. 展开更多
关键词 SREBP LIVER LIPID
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部